Tonix Pharmaceuticals Reports First Quarter 2026 Financial Results and Operational Highlights
Tonix Pharmaceuticals Holding Corp. In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA®, 3,588 patients…
Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand access
New, lower list price of $675 per month across Wegovy®, Ozempic®, and Rybelsus®, effective January 1, 2027, addresses…
WHO demands countries step up mental health spending – POLITICO
Governments in WHO’s Europe region spent $51.76 per capita in 2024 on mental health, far more than any…